You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 05 Mar 467.90 -6.10
(-1.29%)
OPEN

471.30

HIGH

474.25

LOW

465.05

NSE 00:00 | 05 Mar 467.95 -5.75
(-1.21%)
OPEN

473.90

HIGH

474.55

LOW

465.00

OPEN 471.30
PREVIOUS CLOSE 474.00
VOLUME 86440
52-Week high 572.70
52-Week low 168.00
P/E 8.35
Mkt Cap.(Rs cr) 13,204
Buy Price 467.90
Buy Qty 10.00
Sell Price 467.90
Sell Qty 2.00
OPEN 471.30
CLOSE 474.00
VOLUME 86440
52-Week high 572.70
52-Week low 168.00
P/E 8.35
Mkt Cap.(Rs cr) 13,204
Buy Price 467.90
Buy Qty 10.00
Sell Price 467.90
Sell Qty 2.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   13,204
EPS - TTM () [*S] 56.04
P/E Ratio (X) [*S] 8.35
Face Value ()   1
Latest Dividend (%)   250.00
Latest Dividend Date 17 Sep 2020
Dividend Yield (%) 0.53
Book Value / Share () [*S] 497.03
P/B Ratio () [*S] 0.94
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2020 Dec 2019 % Chg
Net Sales 2786.77 2735.56 1.87
Other Income 28.51 32.96 -13.5
Total Income 2815.27 2768.52 1.69
Total Expenses 2256.69 2295.49 -1.69
Operating Profit 558.58 473.04 18.08
Net Profit 248.18 190.84 30.05
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alembic Pharma 916.85 -0.56 18020.69
Natco Pharma 832.75 -0.48 15185.20
Ajanta Pharma 1751.45 0.61 15158.80
Glenmark Pharma. 467.90 -1.29 13204.14
Suven Pharma 479.60 -1.69 12210.62
Jubilant Pharmo 759.40 -3.10 12097.24
P & G Health Ltd 6721.05 0.31 11156.94
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.63
Banks/FIs 0.79
FIIs 26.48
Insurance 0.00
Mutual Funds 3.33
Indian Public 14.95
Custodians 0.00
Other 2.51
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
19/08/2020 Nirmal Bang Accumulate 481 PDF IconDetails
19/08/2020 Elara Capital Accumulate 481 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.19% 0.38% 2.66% 2.81%
1 Month -7.06% -7.01% -0.64% 0.09%
3 Month -7.05% -7.01% 11.81% 12.67%
6 Month -1.72% -1.83% 31.41% 31.80%
1 Year 61.34% 61.03% 31.02% 32.56%
3 Year -15.04% -15.13% 49.36% 44.21%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 465.05
474.25
Week Low/High 462.00
482.00
Month Low/High 443.90
513.00
YEAR Low/High 168.00
573.00
All TIME Low/High 1.89
1262.00
.